Is Avenue Therapeutics, Inc. (ATXI) a Buy, Sell, or Hold?
OTC : ATXI
Avenue Therapeutics, Inc. — Competitors
$0.2551 USD
$0 (0.0%)
- Volume
- 10
- Average Volume
- 3.24K
- Market Capitalization
- $840.55K
- P/E Ratio
- -0.30
- Dividend Yield
- 0.00%
- Price Target
- $12.00
- Year High
- $0.97
- Year Low
- $0.15
- Day High
- —
- Day Low
- —
- Payout Ratio
- $0.00
- Current Ratio
- $1.38
ATXI vs. The Competition
| Properties | ATXI | ADTX | ARDS | DRMA |
|---|---|---|---|---|
| Market Cap | $840.55K | $2.59M | $4457 | $736.08K |
| Shares Outstanding | $3.29M | $997.98M | $44.57M | $681.56K |
| P/E Ratio | -0.3 | -0.0 | -0.0 | -0.25 |
| EPS | -0.84 | -2575.18 | -1.64 | -2.08 |
| Day Low | 0.2551 | 0.0025 | 0.0001 | 1.08 |
| Day High | 0.27 | 0.0027 | 0.00145 | 1.11 |
| Year Low | 0.15 | 0.002 | 0.0001 | 0.951 |
| Year High | 0.9699 | 28801.44 | 0.05 | 6.575 |
| Average Price 50 | 0.30606 | 0.01832 | 0.000533 | 1.2512 |
| Average Price 200 | 0.43418 | 348.51434 | 0.00057 | 1.78909 |
| Volume | 10 | - | 10 | - |
| Average Volume | - | - | - | - |